# Effect of a Probiotic, Lactobacillus FARCIMINIS, in Diarrhea Predominant IBS Patients

> **NCT00561535** · PHASE2 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 60 (actual)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Lactobacillus FARCIMINIS
- **DIETARY_SUPPLEMENT:** placebo (starch)

## Key facts

- **NCT ID:** NCT00561535
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2010-05
- **Final completion:** 2010-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2011-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00561535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00561535, "Effect of a Probiotic, Lactobacillus FARCIMINIS, in Diarrhea Predominant IBS Patients". Retrieved via AI Analytics 2026-08-21 from https://api.ai-analytics.org/clinical/NCT00561535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*